X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
index medicus (10) 10
female (9) 9
male (9) 9
antibodies, monoclonal - therapeutic use (8) 8
drug therapy (7) 7
middle aged (7) 7
adult (6) 6
treatment outcome (6) 6
abridged index medicus (5) 5
antibodies, monoclonal - adverse effects (5) 5
biomarkers (5) 5
rheumatology (5) 5
antirheumatic agents - therapeutic use (4) 4
biomarkers - blood (4) 4
double-blind method (4) 4
patient outcomes (4) 4
remission induction (4) 4
research (4) 4
tumor necrosis factor-tnf (4) 4
aged (3) 3
arthritis, rheumatoid - drug therapy (3) 3
clinical trials (3) 3
drug therapy, combination (3) 3
infliximab (3) 3
psoriasis (3) 3
rheumatoid arthritis (3) 3
severity of illness index (3) 3
studies (3) 3
therapy (3) 3
1506 (2) 2
adolescent (2) 2
analysis (2) 2
anti-tnf (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antirheumatic agents - adverse effects (2) 2
care and treatment (2) 2
clinical and epidemiological research (2) 2
combination (2) 2
cytokines (2) 2
disease (2) 2
disease-activity (2) 2
dosage and administration (2) 2
dose-response relationship (2) 2
dose-response relationship, drug (2) 2
efficacy (2) 2
enzyme-linked immunosorbent assay (2) 2
etanercept (2) 2
il-23 (2) 2
immunoglobulin g - therapeutic use (2) 2
immunology (2) 2
inflammation (2) 2
inflammatory diseases (2) 2
injections, subcutaneous (2) 2
insulin (2) 2
interleukin 23 (2) 2
internal medicine (2) 2
medicine, general & internal (2) 2
methotrexate (2) 2
methotrexate - therapeutic use (2) 2
monoclonal antibodies (2) 2
monoclonal-antibody (2) 2
patients (2) 2
physiological aspects (2) 2
proteins (2) 2
receptors, tumor necrosis factor - therapeutic use (2) 2
rheumatoid-arthritis (2) 2
safety (2) 2
skin (2) 2
trial (2) 2
tumor necrosis factor-alpha - antagonists & inhibitors (2) 2
4 inhibitor (1) 1
activated protein-c (1) 1
activation (1) 1
active control (1) 1
acute-phase proteins (1) 1
adalimumab (1) 1
adamantane - administration & dosage (1) 1
adamantane - adverse effects (1) 1
adamantane - analogs & derivatives (1) 1
agents (1) 1
allergy (1) 1
allergy and immunology (1) 1
alpha (1) 1
analysis of variance (1) 1
ankylosing spondylitis (1) 1
ankylosing-spondylitis (1) 1
antagonists (1) 1
anti-beta-glycoprotein-i antibodies (1) 1
anti-inflammatory agents - adverse effects (1) 1
anti-inflammatory agents - therapeutic use (1) 1
anti-tnf-alpha (1) 1
antibodies, anticardiolipin - blood (1) 1
antibodies, anticardiolipin - immunology (1) 1
antibodies, monoclonal - chemistry (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal, humanized (1) 1
antibody specificity (1) 1
anticoagulant (1) 1
antidiabetic drug (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10080, pp. 1699 - 1709
Summary Background The interleukin-23 pathway is implicated genetically and biologically in the pathogenesis of Crohn's disease. We aimed to assess the... 
Internal Medicine | TRIAL | CELLS | MEDICINE, GENERAL & INTERNAL | ANTI-TNF | INFLAMMATORY-BOWEL-DISEASE | EFFICACY | ULCERATIVE-COLITIS | NECROSIS-FACTOR ANTAGONISTS | ANTITUMOR | MAINTENANCE THERAPY | FACTOR-ALPHA | Severity of Illness Index | Interleukin-23 Subunit p19 - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Remission Induction | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal - administration & dosage | Crohn Disease - drug therapy | Adolescent | Gastrointestinal Agents - therapeutic use | Adult | Female | Aged | Gastrointestinal Agents - adverse effects | Clinical trials | Monoclonal antibodies | Medicine, Experimental | Medical research | Interleukins | Intravenous administration | Pathogenesis | Mucosa | Interleukin | Interleukin 23 | Antagonists | Intravenous therapy | Randomization | Endoscopes | Motivation | Gastroenterology | Remission | Tumor necrosis factor-TNF | Colon | Safety | Active control | Chronic illnesses | Psoriasis | Cytokines | Ileitis | Nausea | Inflammation | Crohn's disease | Disease control | Patients | Ileum | Crohns disease | Inflammatory bowel disease | Interactive systems | Tumor necrosis factor | Ulcers | TNF inhibitors | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 06/2019, Volume 143, Issue 6, pp. 2158 - 2169
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 07/2007, Volume 66, Issue 7, pp. 893 - 899
Journal Article
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 05/2007, Volume 146, Issue 9, pp. 621 - 630
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 07/2009, Volume 374, Issue 9685, p. 210
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(09)60506-7 Byline: Josef S Smolen (a), Jonathan Kay (b),... 
Drug therapy | Rheumatoid arthritis | Research | Studies | Immunization | Monoclonal antibodies | Inflammatory diseases | Clinical outcomes
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2014, Volume 16, Issue 5, pp. 443 - 450
Aims To evaluate the efficacy and safety of saxagliptin as add-on therapy in adults with type 2 diabetes with inadequate glycaemic control on metformin plus a... 
clinical trial | type 2 diabetes | DPP | antidiabetic drug | glycaemic control | incretin therapy | 4 inhibitor | Incretin therapy | Type 2 diabetes | Clinical trial | Antidiabetic drug | DPP-4 inhibitor | Glycaemic control | INSULIN | MONOTHERAPY | ENDOCRINOLOGY & METABOLISM | MELLITUS | COMBINATION | Hypoglycemia - epidemiology | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Thailand - epidemiology | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Canada - epidemiology | Hypoglycemic Agents - administration & dosage | Adult | Female | Hypoglycemia - blood | Sulfonylurea Compounds - administration & dosage | Metformin - administration & dosage | Adamantane - administration & dosage | Drug Therapy, Combination | Korea - epidemiology | Adamantane - adverse effects | Adamantane - analogs & derivatives | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptides - adverse effects | India - epidemiology | Treatment Outcome | United Kingdom | Hypoglycemia - drug therapy | Australia - epidemiology | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Dipeptides - administration & dosage | Diabetes Mellitus, Type 2 - blood | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Glucose metabolism | Care and treatment | Analysis | Clinical trials | Hypoglycemic agents | Glucose | Dextrose | Diabetes therapy | Confidence intervals | Drug therapy | Diabetes | Index Medicus
Journal Article
Политикологија религије, ISSN 1820-6581, 2013, Issue 1, pp. 151 - 169
This paper is concerned with the way energy requirements in the last three decades have seen a response from local communities who wish to express their love... 
Politics / Political Sciences
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.